Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
ENDRA Life Sciences Inc. (NDRA) had Weighted-Average Shares Outstanding (Diluted) of 0.20M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-11.51M |
|
-- |
|
-- |
|
$10.82M |
|
$-10.82M |
|
$-0.69M |
|
$-11.51M |
|
$-11.51M |
|
$-11.51M |
|
$-11.51M |
|
$-11.51M |
|
$-11.51M |
|
$-10.82M |
|
$-10.61M |
|
0.20M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
0.20M |
$-56.94 |
|
$-56.94 |
|
| Balance Sheet Financials | |
$3.43M |
|
$0.07M |
|
$1.02M |
|
$4.45M |
|
$0.61M |
|
-- |
|
$1.29M |
|
$1.89M |
|
$2.56M |
|
$2.56M |
|
$2.56M |
|
0.54M |
|
| Cash Flow Statement Financials | |
$-7.40M |
|
$-0.01M |
|
$7.81M |
|
$2.83M |
|
$3.23M |
|
$0.40M |
|
$0.57M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-449.47% |
|
-449.46% |
|
-258.47% |
|
-449.46% |
|
$4.77 |
|
$-36.70 |
|
$-36.64 |
|